These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32916137)

  • 1. Predicting Oral Absorption of fenofibrate in Lipid-Based Drug Delivery Systems by Combining In Vitro Lipolysis with the Mucus-PVPA Permeability Model.
    Falavigna M; Klitgaard M; Berthelsen R; Müllertz A; Flaten GE
    J Pharm Sci; 2021 Jan; 110(1):208-216. PubMed ID: 32916137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous assessment of in vitro lipolysis and permeation in the mucus-PVPA model to predict oral absorption of a poorly water soluble drug in SNEDDSs.
    Falavigna M; Brurok S; Klitgaard M; Flaten GE
    Int J Pharm; 2021 Mar; 596():120258. PubMed ID: 33486034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.
    Borkar N; Xia D; Holm R; Gan Y; Müllertz A; Yang M; Mu H
    Eur J Pharm Sci; 2014 Jan; 51():204-10. PubMed ID: 24134899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using in vitro lipolysis and SPECT/CT in vivo imaging to understand oral absorption of fenofibrate from lipid-based drug delivery systems.
    Tran T; Bønløkke P; Rodríguez-Rodríguez C; Nosrati Z; Esquinas PL; Borkar N; Plum J; Strindberg S; Karagiozov S; Rades T; Müllertz A; Saatchi K; Häfeli UO
    J Control Release; 2020 Jan; 317():375-384. PubMed ID: 31765705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the Oral Absorption from Self-Nanoemulsifying Drug Delivery Systems Using an In Vitro Lipolysis-Permeation Method.
    Klitgaard M; Müllertz A; Berthelsen R
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33918449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro.
    Keemink J; Mårtensson E; Bergström CAS
    Mol Pharm; 2019 Mar; 16(3):921-930. PubMed ID: 30628771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations.
    Kollipara S; Gandhi RK
    Acta Pharm Sin B; 2014 Oct; 4(5):333-49. PubMed ID: 26579403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suitability of Artificial Membranes in Lipolysis-Permeation Assays of Oral Lipid-Based Formulations.
    Hedge OJ; Bergström CAS
    Pharm Res; 2020 May; 37(6):99. PubMed ID: 32435855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenofibrate oral absorption from SNEDDS and super-SNEDDS is not significantly affected by lipase inhibition in rats.
    Michaelsen MH; Siqueira Jørgensen SD; Abdi IM; Wasan KM; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2019 Sep; 142():258-264. PubMed ID: 31276759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mimicking regional and fasted/fed state conditions in the intestine with the mucus-PVPA in vitro model: The impact of pH and simulated intestinal fluids on drug permeability.
    Falavigna M; Klitgaard M; Steene E; Flaten GE
    Eur J Pharm Sci; 2019 Apr; 132():44-54. PubMed ID: 30822502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) Containing Rice Bran Oil for Enhanced Fenofibrate Oral Delivery: In Vitro Digestion, Ex Vivo Permeability, and In Vivo Bioavailability Studies.
    Karavasili C; Andreadis II; Tsantarliotou MP; Taitzoglou IA; Chatzopoulou P; Katsantonis D; Zacharis CK; Markopoulou C; Fatouros DG
    AAPS PharmSciTech; 2020 Jul; 21(6):208. PubMed ID: 32725343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
    Alskär LC; Parrow A; Keemink J; Johansson P; Abrahamsson B; Bergström CAS
    J Control Release; 2019 Jun; 304():90-100. PubMed ID: 31047962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction with biliary and pancreatic fluids drives supersaturation and drug absorption from lipid-based formulations of low (saquinavir) and high (fenofibrate) permeability poorly soluble drugs.
    Suys EJA; Brundel DHS; Chalmers DK; Pouton CW; Porter CJH
    J Control Release; 2021 Mar; 331():45-61. PubMed ID: 33450318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucus-PVPA (mucus Phospholipid Vesicle-based Permeation Assay): An artificial permeability tool for drug screening and formulation development.
    Falavigna M; Klitgaard M; Brase C; Ternullo S; Škalko-Basnet N; Flaten GE
    Int J Pharm; 2018 Feb; 537(1-2):213-222. PubMed ID: 29288094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IVIVC in oral absorption for fenofibrate immediate release tablets using a dissolution/permeation system.
    Buch P; Langguth P; Kataoka M; Yamashita S
    J Pharm Sci; 2009 Jun; 98(6):2001-9. PubMed ID: 18855916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral bioavailability of cinnarizine in dogs: relation to SNEDDS droplet size, drug solubility and in vitro precipitation.
    Larsen AT; Ohlsson AG; Polentarutti B; Barker RA; Phillips AR; Abu-Rmaileh R; Dickinson PA; Abrahamsson B; Ostergaard J; Müllertz A
    Eur J Pharm Sci; 2013 Jan; 48(1-2):339-50. PubMed ID: 23178440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based Formulation.
    Suys EJA; Chalmers DK; Pouton CW; Porter CJH
    Mol Pharm; 2018 Jun; 15(6):2355-2371. PubMed ID: 29659287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kolliphor surfactants affect solubilization and bioavailability of fenofibrate. Studies of in vitro digestion and absorption in rats.
    Berthelsen R; Holm R; Jacobsen J; Kristensen J; Abrahamsson B; Müllertz A
    Mol Pharm; 2015 Apr; 12(4):1062-71. PubMed ID: 25679417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Cellular Monolayers and an Artificial Membrane as Absorptive Membranes in the in vitro Lipolysis-permeation Assay.
    Keemink J; Hedge OJ; Bianco V; Hubert M; Bergström CAS
    J Pharm Sci; 2022 Jan; 111(1):175-184. PubMed ID: 34516987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.